Revenue: The sum of all revenue fields included for a company's operating activities.
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Revenue of $695.42M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$695.42M |
$12.20M |
|
$439.53M |
|
$255.89M |
|
$595.07M |
|
$100.35M |
|
$-62.86M |
|
$37.49M |
|
$37.49M |
|
$24.62M |
|
$24.62M |
|
$24.62M |
|
$24.62M |
|
$100.35M |
|
$167.32M |
|
311.05M |
|
323.96M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$1.51B |
|
$427.23M |
|
$1.85B |
|
$3.37B |
|
$1.08B |
|
$2.15B |
|
$2.42B |
|
$3.50B |
|
$-132.00M |
|
$-1.42B |
|
$-132.00M |
|
313.38M |
|
| Cash Flow Statement Financials | |
$7.41M |
|
$-17.80M |
|
$-39.17M |
|
$118.42M |
|
$68.39M |
|
$-50.03M |
|
$7.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
1.07 |
|
-18.76 |
|
36.80% |
|
14.43% |
|
14.43% |
|
-- |
|
5.39% |
|
1.75% |
|
$-6.19M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.73 |
|
0.92 |
|
97.67 |
|
-18.65% |
|
-1.74% |
|
0.73% |
|
1.22% |
|
$-0.42 |
|
$-0.02 |
|
$0.02 |
|